Skip to main content
TipRanks
Go Ultimate75% OFF

Michael Bristow Insider Profile

4 Followers

Michael Bristow, Pres. & Chief Executive Offic, Director at Oruka Therapeutics, holds 4.81K shares in Oruka Therapeutics (Ticker: ORKA).

Michael Bristow's Trading History

ORKA
Oruka Therapeutics
Apr 05, 2017Pres. & Chief Executive Offic, DirectorUninformative Sell1.74K$506.52K
ORKA
Insider Shares: 4.81K (0.03%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Apr 05, 2017Uninformative Sell$1.74K720$2.41―
Mar 01, 2017Uninformative Sell$1.99K763$2.61―
Sep 21, 2016Uninformative Sell$5.70K1,972$2.89―
Apr 06, 2016Uninformative Sell$2.55K724$3.52―
Mar 02, 2016Uninformative Sell$2.63K752$3.50―

You May Also Like

Michael Bristow insider profile FAQ

What is the percentage of profitable transactions made by Michael Bristow?
The percentage of profitable transactions made by Michael Bristow is 50%.
What is the average return per transaction made by Michael Bristow?
The average return per transaction made by Michael Bristow is 6.10%.
What stocks does Michael Bristow hold?
Michael Bristow holds: ORKA stocks.
What was Michael Bristow’s latest transaction?
Michael Bristow’s latest transaction was an Uninformative Sell of $1.74K.
What was Michael Bristow's most profitable transaction?
Michael Bristow’s most profitable transaction was an Informative Buy of ORKA stock on October 15, 2009. The return on the trade was 26.80%.
What is Michael Bristow's role in Oruka Therapeutics?
Michael Bristow's role in Oruka Therapeutics is Pres. & Chief Executive Offic, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.